Memorial Hospital Research Laboratories

The Samuel Singer Lab

Research

Pictured: Samuel Singer
Samuel Singer, MD

Soft tissue sarcoma is a heterogeneous disease with more than 50 histological subtypes, which have diverse biological behavior and – in many cases – unique genetics. Many sarcoma subtypes respond poorly to chemotherapy, so there is an urgent need for better treatment options for patients whose disease cannot be cured surgically. The major focus of my research is the discovery of genetic and epigenetic alterations in sarcoma to gain insight into sarcoma biology and find new targets for therapy.

View Lab Overview

People

Pictured: Samuel Singer

Samuel Singer, MD

  • Physician-scientist Samuel Singer studies the genomic alterations that define new targets for therapy in sarcoma.
  • MD, Harvard Medical School
View physician profile
Physician profile
Lab Affilations

Open Positions

Experienced Postdoctoral Fellow for a Sarcoma Biology Research Lab

Looking for an experienced Postdoctoral Fellow to join an NIH funded laboratory dedicated to gene target identification and drug discovery in soft tissue sarcoma through a genome-wide genetic and functional analysis.

Apply now